Results 81 to 90 of about 1,279,624 (253)
2-methoxyestradiol enhances p53 protein transduction therapy-associated inhibition of the proliferation of oral cancer cells through the suppression of NFkappaB activity. [PDF]
Protein transduction therapy using poly-arginine peptide can deliver the biologically active proteins. A previous study showed that 11 poly-arginine fused p53 protein (11R-p53) effectively penetrated across the plasma membrane and inhibited the ...
Matsui, Hideki +3 more
core +1 more source
Background The pathogenesis of oral squamous cell carcinoma (OSCC) in never-smoking females remains poorly understood, as these patients lack traditional risk factors.
Sung Min Kim +8 more
doaj +1 more source
Per-oral cross-facial sural nerve graft for facial reanimation
Background Cross-facial nerve graft is considered the treatment of choice for facial reanimation in patients with unilateral facial palsy caused by central facial nerve damage.
Joohee Jeong +10 more
doaj +1 more source
Investigation of the minimum uptake time for quantitative jawbone SPECT
Background The range of imaging times recommended for bone scintigraphy is wide, and uptake times vary across facilities. In our previous quantitative evaluation of jawbone SPECT using [99mTc] Tc-HMDP, we reported that standardized uptake values at the 2-
Hironobu Hata +9 more
doaj +1 more source
Concanavalin A induced autophagy switches to apoptosis [PDF]
Concanavalin A (Con A) is a lectin or carbohydrate binding protein having broad range of significant biological functions such as anti-tumor, anti-viral,anti-inflammatory, anti-proliferative activities.
Panda, Madhusmita
core
Nasopharyngeal Carcinoma in Southeast Asia: Current Landscape and Future Priorities
Nasopharyngeal carcinoma (NPC) remains a major public health concern with a geographically skewed distribution. The disease is endemic in East Asia (particularly China), Southeast Asia (SEA) and South-Central Asia.
Suat Ming Chan +2 more
doaj +1 more source
Oral leukoplakia and oral cancer
Takeshi, Onda +3 more
openaire +2 more sources
Phase 1 Clinical and Pharmacokinetics Evaluation of Oral CI-1033 in Patients with Refractory Cancer [PDF]
John Nemunaitis +11 more
openalex +1 more source

